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Summary
SpvC is encoded by the Salmonella virulence
plasmid. We have investigated the biochemical func-
tion of SpvC and the mechanism by which it is
secreted by bacteria and translocated into infected
macrophages. We constructed a strain carrying a
deletion in spvC and showed that the strain is attenu-
ated for systemic virulence in mice. SpvC can be
secreted in vitro by either the SPI-1 or SPI-2 type III
secretion systems. Cell biological and genetic experi-
ments showed that translocation of the protein into
the cytosol of macrophages by intracellular bacteria
is dependent on the SPI-2 T3SS. Using antibodies
specific to phospho-amino acids and mass spectrom-
etry we demonstrate that SpvC has phosphothreo-
nine lyase activity on full-length phospho-Erk (pErk)
and a synthetic 13-amino-acid phospho-peptide con-
taining the TXY motif. A Salmonella strain expressing
spvC from a plasmid downregulated cytokine release
from infected cells.
Introduction
Salmonella enterica serovar Typhimurium (S. Typhimu-
rium) is a facultative intracellular pathogen that causes a
self-limiting gastroenteritis in humans and, less com-
monly, a non-typhoidal bacteremia (Velge et al., 2005).
S. Typhimurium pathogenesis depends upon a large
number of virulence proteins. Some of these, called effec-
tors, are injected into the host cell by two specialized
protein translocation machineries – type three secretion
systems (T3SS). The T3SS encoded within Salmonella
pathogenicity island 1 (SPI-1) is produced by extracellular
bacteria and delivers effectors across the host cell plasma
membrane; these are necessary for bacterial internaliza-
tion and the early stages of Salmonella-containing
vacuole (SCV) formation (Zhou and Galan, 2001; Schlum-
berger and Hardt, 2006). The SPI-2-encoded T3SS is
activated by internalized Salmonella and translocates
effectors across the vacuolar membrane. These support
bacterial replication in epithelial cells and macrophages,
interfere with MHC class II presentation (Mitchell et al.,
2004) and also induce macrophage motility (Worley et al.,
2006) and cytotoxicity (Rytkonen et al., 2007). Together,
SPI-2 T3SS effectors are required for systemic virulence
in the murine model of salmonellosis (Shea et al., 1996;
Waterman and Holden, 2003).
Some Salmonella serovars carry plasmids which share
a highly conserved locus called the spv (salmonella
plasmid virulence) operon (Boyd and Hartl, 1998). This
operon is primarily responsible for the virulence pheno-
type associated with these plasmids (Gulig et al., 1993;
Gulig and Doyle, 1993; Chu and Chiu, 2006). It has been
suggested that spv genes are important for pathogenesis
in humans as spv-carrying strains dominate among clini-
cal isolates from patients with non-typhoidal bacteremia
(Montenegro et al., 1991; Fierer et al., 1992). spv genes
are also necessary for full virulence of S. Typhimurium in
mouse models of systemic infection (Gulig and Doyle,
1993), but their functions are poorly understood. The
operon consists of five genes, named spvR, A, B, C and
D (Krause et al., 1992). The expression of spv genes is
strongly induced in intracellular bacteria in tissue culture,
in animal infection models and in media mimicking the ion
composition and low pH within the SCV (Wilson et al.,
1997; Wilson and Gulig, 1998; Ygberg et al., 2006). The
expression of the operon depends on spvR, which
encodes a positive transcriptional regulator (Fang et al.,
1991; Krause et al., 1992; Grob and Guiney, 1996). spvA
seems to be dispensable for virulence and its function
is unknown (Roudier et al., 1992; Wilson and Gulig,
1998). spvB encodes an actin-ribosyltransferase, which
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upon delivery to host cells modifies actin and blocks its
polymerization into F-actin filaments (Otto et al., 2000;
Lesnick et al., 2001; Tezcan-Merdol et al., 2001). During
infections of macrophages in vitro, the loss of actin
cytoskeleton results in a form of delayed cytotoxicity,
manifested by cell detachment and apoptosis of infected
cells (Libby et al., 2000). The function of spvD is unknown
but it contributes to virulence of S. Typhimurium in mice
(Matsui et al., 2001).
SpvC shares 63% identity at the amino acid level with
OspF of Shigella flexneri. Two recent reports demonstrated
that OspF can remove phosphate groups from host cell
mitogen-activated protein kinases (MAPKs) thereby inac-
tivating them (Arbibe et al., 2007; Li et al., 2007). OspF
interference with MAPK-pathways blocks the activation of
a subset of NF-kB-regulated genes resulting in impaired
chemokine signalling and compromised recruitment of
polymorphonuclear leukocytes to infected tissues (Arbibe
et al., 2007). OspF removes phosphate groups of Erk and
p38 MAPKs by either phosphatase (Arbibe et al., 2007) or
phosphothreonine lyase (Li et al., 2007) activity. Experi-
ments with recombinant SpvC and cells producing SpvC
following transfection suggested that it is also capable of
inactivating MAPKs (Li et al., 2007).
In this study we have investigated the function of SpvC
in more detail. We show that SpvC is important for Sal-
monella virulence in mice and that it can be secreted by
either the SPI-1 or SPI-2 T3SS. Translocation of SpvC
into the cytosol of macrophages is shown to be dependent
on the SPI-2 T3SS. Using antibodies specific to phospho-
amino acids and mass spectrometry we demonstrate that
SpvC has phosphothreonine lyase activity on full-length
phospho-Erk (pErk) and a synthetic 13-amino-acid
phospho-peptide containing the TXY motif. A Salmonella
strain expressing spvC from a plasmid downregulated
cytokine release from infected cells.
Results
SpvC is a Salmonella T3SS effector
spvC is essential for full virulence of S. Typhimurium in
mice (Matsui et al., 2001) but it has not been established
if SpvC functions within the bacterium or is an effector
protein translocated into the host cells during or after
invasion. To investigate the possibility that SpvC is a
secreted effector we used homologous recombination to
introduce a double haemagglutinin (2HA) tag at the
C-terminus of SpvC on the Salmonella virulence plasmid
(Uzzau et al., 2001). Then we checked production of
SpvC-2HA by Salmonella grown in Luria–Bertani (LB) or
MgM-MES media. SpvC-2HA could only be detected at a
very low level in the stationary growth phase in LB
medium, but a strong induction was observed during
exponential growth phase in MgM-MES (data not shown).
Production of SpvC-2HA in MgM-MES medium (which
mimics the luminal environment of the SCV and which
induces expression of SPI-2 T3SS genes) raised the pos-
sibility that SpvC might be translocated by the SPI-2
T3SS. Salmonella strains carrying mutations in SPI-1 or
SPI-2 genes and expressing SpvC-2HA from the viru-
lence plasmid were grown in MgM-MES medium. Immu-
noblotting was used to detect HA-tagged protein in
bacterial lysates and on the plastic surface of the culture
vessels, which adsorbs secreted proteins (Daefler, 1999).
Similar amounts of SpvC-2HA were present in lysates
from wild-type bacteria and strains carrying mutations in
prgH and ssaV (which inactivate the SPI-1 and SPI-2
T3SSs respectively) (Fig. 1A). SpvC-2HA was also
present on the plastic surface of the tubes in which wild-
type and prgH mutant bacteria were cultured, but it was
absent from the surface of the tube containing the ssaV
mutant strain, indicating that SpvC is secreted in a SPI-2
T3SS-dependent manner (Fig. 1A). To test the activity
of the SPI-2 T3SS in the strains used, we examined
the secretion of SseB, a component of the SPI-2 T3SS
translocon (Beuzon et al., 1999). As expected, SseB was
detected in secreted fractions from wild-type Salmonella
and prgH mutant bacteria but not from the ssaV mutant
(Fig. 1A). When SpvC-2HA was overproduced from the
Fig. 1. In vitro secretion of SpvC-2HA.
A. Secretion of double HA-tagged SpvC produced from the
virulence plasmid by Salmonella strains cultured in low magnesium
minimal medium (MgM-MES): 1 – spvC-2HA, 2 – prgHspvC-2HA,
3 – ssaVspvC-2HA.
B. Constitutively produced SpvC-2HA is secreted in SPI-1
T3SS-dependent manner by Salmonella grown in LB medium: 1 –
WT pspvC, 2 – prgHpspvC, 3 – ssaVpspvC. Samples were probed
for SseB and SopB to confirm the activity of SPI-2 and SPI-1
T3SSs respectively.
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constitutive tet promoter of pACYC184 (pspvC), a SPI-1
T3SS-dependent secretion was detected in SPI-1-
inducing conditions (Fig. 1B).
To investigate if SpvC is translocated into infected
cells, J774 macrophage-like cells were infected with
wild-type Salmonella expressing SpvC-2HA from the
virulence plasmid. Using antibodies against the 2HA
tag we could not detect any translocated SpvC-2HA
within infected cells by immunofluorescence microscopy.
However, after infection of macrophages with the strain
harbouring pspvC it was possible to detect translocated
SpvC-2HA 16 h post challenge. The amounts of detect-
able SpvC-2HA increased when infected cells were incu-
bated for 2 h prior to fixation with MG132, a proteasome
inhibitor (Fig. 2A). In the majority of examined cells,
translocated SpvC-2HA appeared to be distributed
evenly in the cytoplasm. These results suggest that
relatively small amounts of SpvC are translocated into
the cytoplasm of infected cells, where it is prone to deg-
radation. No colocalization with the SCV membrane
or accumulation in the nucleus was noted (Fig. 2B).
To confirm that translocation of SpvC-2HA is T3SS-
dependent we infected J774 cells with prgH, ssaV and
double prgH ssaV mutants overexpressing SpvC-2HA.
Only infection with the prgH mutant led to detectable
SpvC-2HA in the cytoplasm of infected cells (Fig. 2A).
This result is consistent with that of the in vitro secretion
experiment, and indicates that a functional SPI-2 T3SS
is necessary for translocation of SpvC-2HA.
Virulence tests
To investigate the role of SpvC in virulence, a clean dele-
tion mutant strain (DspvC) was constructed as described
in Experimental procedures. Its virulence was tested in
mixed infections with a kanamycin-resistant isogenic strain
(STM0857) whose virulence level is indistinguishable from
that of wild-type S. Typhimurium strain 12023 (J. Poh and
D.W. Holden, unpubl. data). BALB/c mice were inoculated
intraperitoneally with 5 ¥ 104 cfu DspvC and 5 ¥ 104 cfu of
STM0857. After 96 h of infection mice were sacrificed and
bacteria were recovered from spleens and plated on LB
and LB agar plates supplemented with kanamycin to dis-
criminate the strains. The competitive index (CI) of DspvC
strain was 0.51 (SD  0.069) indicating an attenuation in
virulence. When mice were coinfected with the DspvC
strain and DspvC carrying pspvC, the CI for DspvC was
0.33 (SD  0.085), showing that the attenuation of the
Fig. 2. SpvC-2HA is translocated into
infected macrophages in SPI-2
T3SS-dependent manner.
A. J774 cells were infected for 16 h with
Salmonella strains carrying pACYCspvC-2HA;
10 mg ml-1 of a proteasome inhibitor MG132
was added to the culture media for the last
2 h of infection. Samples were fixed and
labeled with antibodies to visualize
Salmonella and SpvC-2HA (red and green,
respectively, on merged images). Similar
results were observed in infected HeLa cells
(data not shown).
B. Translocated SpvC-2HA does not
accumulate in the nucleus of infected cells.
PFA-fixed samples were labeled with
antibodies to visualize Salmonella (blue),
SpvC-2HA (green) and lamin, a nuclear
membrane protein (red).
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DspvC strain is due to the loss of SpvC, and that SpvC-2HA
is a functional protein. Next, we quantified the attenuation
caused by the DspvC mutation in strains carrying muta-
tions in essential genes for either the SPI-1 (prgH) or SPI-2
(ssaV) T3SS. Mixed infections with prgHDspvC and prgH
mutants showed that the lack of spvC has an additive effect
on the attenuation of prgH mutant, indicating that functions
of prgH and spvC are unrelated. By contrast, the spvC
mutation did not cause any significant additional attenua-
tion to that observed for the ssaV mutant. This provides
genetic evidence that the functions of ssaV and spvC are
related (Fig. 3). Together with results shown in Figs 1 and
2, these results strongly suggest that SpvC is translocated
by the SPI-2 T3SS in vivo.
The spvC mutant was also compared with the wild-type
strain in terms of its ability to replicate inside host cells.
In standard assays involving macrophage-like RAW cells
(Ruiz-Albert et al., 2002), there were no significant differ-
ences between the two strains (results not shown).
Effect of SpvC on Erk activation in infected cells
OspF inactivates MAP kinases Erk, p38 (Arbibe et al.,
2007; Li et al., 2007) and possibly JNK (Li et al., 2007). As
SpvC is translocated into host cells and is 63% identical to
OspF, we examined its effect on the activation state of
host MAP kinase Erk1/2. J774 cells were infected with
different strains of S. Typhimurium for 16 h (Fig. 4). Imme-
diately before fixation for immunofluorescence micros-
copy (Fig. 4A) or cell lysis for Western blotting (Fig. 4B),
phorbol-12-myristate 13-acetate (PMA) was added to
induce the activation of Erk. This was detected by probing
samples with antibodies recognizing double phosphory-
lated Erk (pErk) on threonine and tyrosine residues of the
TXY motif. As shown in Fig. 4, low levels of activated Erk
were detected in uninfected, PMA-untreated J774 cells.
PMA treatment induced Erk phosphorylation in uninfected
control cells, as well as in cells infected with either the
DspvC or ssaV mutant. However, infection with wild-type
S. Typhimurium or the complemented DspvC strain
strongly reduced Erk activation by PMA treatment. These
results show that both SpvC and a functional SPI-2 T3SS
are necessary for Erk inactivation.
Purified SpvC inactivates Erk and JNK in vitro and is
not sensitive to vanadate inhibition
To establish if SpvC is sufficient for Erk inactivation we
purified GST–SpvC (Fig. S1), GST and SpvC-His and
used these in in vitro dephosphorylation assays with puri-
fied, phosphorylated MAP kinases. A dual specificity MAP
kinase phosphatase 1 (MKP1) was used as a control for
MAP kinase dephosphorylation. Immunoblotting analysis
revealed that MKP1 and GST–SpvC can remove phos-
phate groups from pErk (Fig. 5A). Similar results were
obtained when pJNK was incubated with MKP1 and
GST–SpvC (Fig. 5B). Next we tested the sensitivity of
SpvC to vanadate, a tyrosine phosphatase inhibitor. pErk
was incubated with GST–SpvC in the presence or
absence of vanadate. As a control, MKP1 (which is sus-
ceptible to vanadate inhibition) was used (Charles et al.,
1993). As expected, dephosphorylation of pErk by MKP1
was inhibited by addition of vanadate, but the activity of
SpvC was not (Fig. 5C), indicating that SpvC might not be
a typical dual specificity phosphatase.
SpvC specifically removes phosphate from threonine of
the TXY motif
The antibody used above recognizes double-
phosphorylated Erk on threonine and tyrosine residues in
the conserved activation loop motif TEY. This antibody
does not recognize unphosphorylated Erk or Erk phos-
phorylated on either threonine or tyrosine. Therefore, to
establish if SpvC is a dual specificity enzyme or if it acts
only on phospho-threonine or phospho-tyrosine residues,
we probed MKP1- or SpvC-treated pErk with antibodies
recognizing only phospho-threonine or only phospho-
tyrosine residues. MKP1-treated pErk lost phosphate
groups on both threonine and tyrosine (Fig. 6A). By
contrast, SpvC-treated pErk was negative for phospho-
threonine labelling but remained positive for phospho-
Fig. 3. Lack of spvC causes virulence attenuation of Salmonella
in the mouse model of systemic infection. Canceled-out index (COI)
values show that spvC function can be genetically linked to the
SPI-2 T3SS because the COI of DssaV versus DspvC DssaV was
statistically significant to the CI of the WT versus the DspvC strain
(P < 0.001). Animals were infected for 96 h; horizontal bars indicate
the mean values of CI or COI.
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tyrosine labelling. Furthermore, the anti-phosphotyrosine
antibody gave a stronger signal from the SpvC-treated
pErk sample than from untreated pErk, suggesting that
the presence of phosphate group on the threonine residue
adjacent to the phospho-tyrosine might reduce binding of
anti-phosphotyrosine antibody to double phosphorylated
Erk. These results suggest that SpvC is not a dual spec-
ificity phosphatase but is either a phosphothreonine-
specific phosphatase or, as proposed for OspF (Li et al.,
2007), a phosphothreonine lyase.
SpvC is a phosphothreonine lyase
To discriminate between phosphatase and lyase
activities we analysed a 13-amino-acid diphosphopeptide
[comprising the TEY motif and adjacent amino acids;
Fig. 4. Translocated SpvC prevents Erk phosphorylation upon PMA stimulation.
A. J774 cells were infected for 16 h with the indicated Salmonella strains (blue in merged images), then Erk activation was triggered by 15 min
of incubation with PMA (1 mg ml-1). To assess Erk activation total Erk and phosphorylated Erk (pErk) were visualized with antibodies (red and
green, respectively, in merged images). Similar results were obtained for HeLa cells (data not shown).
B. Western blot analysis of the phosphorylation state of Erk in J774 macrophages infected with different Salmonella strains. Lysates of
infected cells were probed for pErk and total Erk. Brackets indicate two forms of the kinase detected Erk1 (44 kDa) and Erk2 (42 kDa). pErk
bands were quantified using Scion Image software. In both A and B uninfected cells were used as a control for the efficiency of PMA
stimulation.
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Erk2(177–189)] after treatment with SpvC, using mass
spectrometry. MALDI-TOF mass spectra of Erk2(177–
189) before and after treatment with SpvC (Fig. 6B) show
that a mass shift of 98 Da occurred as a result of treat-
ment with the enzyme. The monoisotopic [M + H]+ ion at
m/z 1669.8 of the diphosphorylated peptide (theoretical
m/z 1669.66) was replaced by a product at m/z 1571.8,
which was consistent with the loss of phosphoric acid
(H3PO4). The loss of phosphoric acid from threonine-7 of
the Erk2(177–189) peptide to form dehydrothreonine was
confirmed by MALDI-CID-MS/MS of the precursor ion at
m/z 1571.8 (Fig. 6C). Product ions crucial to the assign-
ment of the site of dephosphorylation (indicated with an
exclamation mark) are the b7 at m/z 754 and y7 at m/z 901.
The mass difference of m/z 83 between the y6 and y7
ions is consistent with dehydrothreonine; threonine at this
position would result in a mass difference of m/z 101.
Phosphorylation at tyrosine-9 was confirmed by the b9 ion
at m/z 1126 and y5 at m/z 689. The MS/MS spectrum of
the dephosphorylated Erk2(177–189) peptide produced
by SpvC treatment (Fig. 6C) is very similar to the spec-
trum of the OspF product obtained by Li et al. (2007). The
compound giving rise to the ion at m/z 1578.0 in the
spectrum of the Erk(177–189) peptide preparation could
not be identified. Despite being lighter by 91 Da, its
MALDI-CID-MS/MS spectrum was almost identical to that
of the ion at m/z 1669.8 (data not shown). This compound
therefore appears to be a peptide that is very similar to the
diphosphorylated Erk(177–189) peptide.
Dephosphorylation of p-Erk2 by SpvC was character-
ized by mass spectrometry of the tryptic peptides pro-
duced by in-gel digestion of the protein after SpvC
treatment and SDS-PAGE. The tryptic peptide VADPDH-
DHTGFLTEYVATR with a single phosphorylation site and
a dehydrothreonine residue, which would be produced
from the p-Erk2 by SpvC acting as lyase, has an expected
[M + H]+ monoisotopic mass of 2206. An ion with this
Fig. 5. Purified GST–SpvC removes phosphate group(s) from
pErk and pJNK in vitro. Phosphorylation status of Erk/JNK was
determined using an antibody specific for double (threonine and
tyrosine) phosphorylated MAP kinases (upper panels in A, B and
C). Antibodies detecting MAP kinases regardless of their
phosphorylation state were used to check the amounts of
pErk/pJNK used (lower panels in A, B and C).
A. One hundred nanograms of pErk were incubated with 30 U
(1 mg) of MAP-kinase phosphatase 1 (MKP1), 400 ng of
GST–SpvC, 400 ng of GST or left untreated as a positive control
for anti-pErk antibody.
B. One hundred nanograms of pJNK were incubated with 30 U
MKP1, 400 ng of GST–SpvC or left untreated as a positive control
for anti-pJNK antibody.
C. Effect of orthovanadate on the activity of MKP1 and GST–SpvC.
Two hundred nanograms of pErk were incubated with 1 mg of
MKP1, 200 ng of GST–SpvC and indicated concentrations of
sodium orthovanadate.
Fig. 6. SpvC has phospholyase activity on phospho-threonine but not phospho-tyrosine residues of pErk.
A. One hundred nanograms of pErk were incubated with 30 U MKP1, 400 ng of GST–SpvC, or left untreated as a positive control for anti-pErk
antibody. Samples were incubated for 1 h at 30°C, and then subjected to SDS-PAGE and blotting. Membranes were probed with antibodies
recognizing double phosphorylated Erk (pErk), phosphothreonine residues (pT), phosphotyrosine residues (pY) or Erk regardless of its
phosphorylation state (Erk).
B. MALDI-TOF spectrum of a synthetic Erk2 diphosphopeptide (DHTGFL-pT-E-pY-VATR) untreated (control) and treated with SpvC. The mass
difference of 98 between the diphosphopeptide ([M + H]+ at m/z 1669.8) and the SpvC-treated product ([M + H]+ at m/z 1571.8) is consistent
with the loss of phosphoric acid HPO3 and H2O.
C. Tandem mass spectrometric (MALDI-CID-MS/MS) analysis of the precursor at m/z 1571.8 from the SpvC-treated fraction. The b- and y-ions
are labelled; those with an exclamation mark indicating ions are crucial to assignment of the sites of phosphorylation (tyrosine-9) and
dehydration (threonine-7). All ions included in the diagram are visible in the spectrum. TD denotes dehydrothreonine and pY phosphotyrosine.
D. CID-MS/MS spectrum of the triply charged precursor ([M + 3H]3+) at m/z 736.0 obtained by LC-ES-MS of the tryptic digest of SpvC-treated
pErk. The y-ions with an exclamation mark are crucial to assignment of the sites of phosphorylation (tyrosine-15) and dehydration
(threonine-13). Double b,y-cleavage ions are indicated by PD and PDHD, and their proposed origins are indicated by horizontal lines above
and below the peptide sequence. TD denotes dehydrothreonine and pY phosphotyrosine. Inset shows the precursor ion at m/z 736.0 in an
LC-MS survey scan recorded at a retention time of 4.96 min.
E. CID-MS/MS spectrum of the triply charged precursor ([M + 3H]3+) at m/z 703.9 obtained by LC-ES-MS of the tryptic digest of SpvC-treated
pErk. The y-ions with an exclamation mark are crucial to assignment of the site of dehydration (threonine-13). TD denotes dehydrothreonine.
Inset shows the precursor ion at m/z 703.9 in an LC-MS survey scan recorded at a retention time of 5.08 min.
1376 P. Mazurkiewicz et al. 
© 2008 The Authors
Journal compilation © 2008 Blackwell Publishing Ltd, Molecular Microbiology, 67, 1371–1383
mass was observed in the MALDI-TOF spectrum of the
tryptic digest of SpvC-treated p-Erk2 (data not shown),
but its intensity was not sufficient for selection as a pre-
cursor ion for MS/MS. The same peptide was detected as
the triply charged [M + 3H]3+ ion at m/z 736 during
LC-ES-MS (Fig. 6D, inset). The CID-MS/MS spectrum of
the triply charged ion at m/z 736 contains product ions
that are consistent with the sequence VADPDHDHTG-
FLTDEpYVATR, where TD indicates dehydrothreonine
and pY indicates phosphotyrosine in the sequence. Ions
crucial to the sequence assignment are present, in par-
ticular the y5 and y7 ions at m/z 689 and 901 respectively.
The proposed double-cleavage ions at m/z 213 and 465
are entirely consistent with the peptide sequence and
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the enhanced cleavage normally observed at prolyl and
aspartatyl residues (Wysocki et al., 2000). In addition to
the tyrosine-phosphorylated tryptic peptide containing
dehydrothreonine, the non-phosphorylated version was
also observed by LC-ES-MS (Fig. 6E). The presence of
this non-phosphorylated peptide product indicates that
the p-Erk2 substrate was not completely phosphorylated
at tyrosine-412, as well as providing additional evidence
for the removal of phosphoric acid from threonine-410 by
SpvC.
Effect of SpvC on proinflammatory immune responses
The action of OspF on MAPKs affects histone modifica-
tion and chromatin accessibility of NF-kB at the IL-8 pro-
moter, and negatively regulates neutrophil recruitment in
infected tissues (Arbibe et al., 2007). We therefore mea-
sured secretion of IL-8 from HeLa cells at different times
after infection with bacterial strains. Infection with wild-
type bacteria induced IL-8 production but no increased
production could be detected in cells infected with the
DspvC mutant (Fig. 7A). However, cells infected with the
DspvCpspvC strain showed significantly less IL-8 produc-
tion compared with the wild-type strain at all time points
tested (P  0.05 for all time points) (Fig. 7A). As TNF-a
production following stimulation of TLR-4 by LPS is
MAPK-dependent (van der Bruggen et al., 1999), we also
examined production of this cytokine by murine J774
macrophages. Time points for sampling were chosen to
coincide with detectable SpvC translocation into host
cells. Again, no significant differences were detected
between cells infected with the wild-type or spvC mutant,
but cells overexpressing SpvC produced less TNF-a at
14, 18 and 21 h post uptake (Fig. 7B). We also infected
BALB/c mice with either the wild-type, spvC mutant or
DspvCpspvC strains. At 4, 24 and 72 h post inoculation,
mouse sera were recovered and analysed for IL-6, IL-10,
MCP-1, INF-g, TNF-a and IL12p70 by ELISA. No statisti-
cally significant differences were detected between mice
infected with these strains (data not shown).
Discussion
Phylogenetic analysis suggests that the spv operon is
widely distributed throughout the subspecies of Salmo-
nella enterica. It is usually carried on the large Salmonella
virulence plasmid, but in some serovars is integrated into
the chromosome (Boyd and Hartl, 1998). The best
characterized Spv protein is SpvB (which is encoded
immediately upstream of spvC in the operon). SpvB ADP-
ribosylates actin and is associated with cytotoxic activity
in infected host cells (Otto et al., 2000; Tezcan-Merdol
et al., 2001; Browne et al., 2002). SpvB must therefore be
translocated into host cells from extracellular or intracel-
lular bacteria. Its cytopathic effects seem to be dependent
on a functional SPI-2 T3SS (Browne et al., 2002), but
paradoxically its secretion into the culture medium in vitro
was reported to be independent of either the SPI-1 or
SPI-2 T3SSs (Gotoh et al., 2003).
Until recently little has been known about the function
of SpvC, apart from its requirement for virulence in mice
(Matsui et al., 2001). Using an epitope-tagged version
produced from its own promoter in the virulence plasmid,
we have shown here that SpvC can be secreted into the
culture medium in either a SPI-1- or SPI-2-dependent
manner, according to which secretion system is activated
by bacterial growth conditions. However, we were unable
to detect translocation of the protein by immunofluores-
cence microscopy following its normal production in
infected cells. Only when SpvC was produced from a
Fig. 7. Effect of Salmonella on cytokine release by infected cells.
ELISA was used to measure amounts of IL-8 released by infected
HeLa cells (A) and TNF-a released by J774 macrophages (B) into
the growth media at the indicated time points. Similar infection
efficiencies was confirmed by microscopy in every experiment.
P-values were calculated for cytokine levels from cells infected with
the DspvCpspvC strain compared with cells infected with WT
bacteria were significantly different (> 0.05) at all time points tested
for A, and at 14, 18 and 21 h for B.
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multicopy plasmid in infected cells that had been treated
with a proteasome inhibitor could its SPI-2 T3SS-
dependent translocation be detected clearly.
Although SpvC was not observed in infected macroph-
ages following expression from its own promoter,
phospho-Erk was detected in the cytoplasm of cells
infected with either the spvC and SPI-2 T3SS null mutant,
but not in cells infected with the wild-type or spvC-
complemented strain (Fig. 4). As SpvC removes phos-
phate groups from Erk, this provides strong indirect
evidence for SPI-2-dependent translocation of SpvC by
wild-type bacteria. Furthermore, virulence tests with
single and double mutants demonstrated that the attenu-
ation caused by mutation of spvC is SPI-2-dependent,
indicating that SpvC uses this secretion system in vivo.
This contrasts with the results of an earlier study in which
a polar spvA mutation had an additive effect on virulence
attenuation of a SPI-2 null mutant (Shea et al., 1996). It is
possible that other protein(s) encoded by the operon
might be functionally independent of the SPI-2 T3SS, but
further work on secretion and translocation of the Spv
proteins is necessary to clarify this issue. Taken together,
the results of this study provide strong evidence that
during intracellular growth of bacteria, SpvC is translo-
cated into the cytosol of macrophages in relatively small
amounts through the SPI-2 T3SS. Whether or not it is also
translocated along with SPI-1 T3SS effectors during inva-
sion of epithelial cells remains to be determined.
There are approximately 31 genes in SPI-2 that encode
the secretion apparatus, translocon, chaperones and at
least two effectors. These, together with genes for several
other effectors located outside SPI-2, are strongly
induced following uptake of bacteria by host cells and
require the SPI-2-encoded SsrA-B two-component
system for their expression (Cirillo et al., 1998). The spv
operon is known to be induced during intracellular growth
in macrophages (Rhen et al., 1993; Eriksson et al., 2003),
but to our knowledge there is no evidence indicating
that its expression is dependent on the SsrA-B two-
component system. Indeed, we found that RNA levels for
spvA, B, C and D were similar in wild-type and ssrA
mutant bacteria that had been grown in conditions that
result in strong expression of the SsrA-SsrB regulon
(Rytkonen et al., 2007; P. Mazurkiewicz and D.W. Holden,
unpubl. results). SlrP and SspH 1 are two other effectors
that can be translocated by either the SPI-1 or SPI-2
T3SSs, and neither seems to be regulated by SsrA-B
(Miao and Miller, 2000). Therefore, the repertoire of SPI-2
T3SS effectors is not restricted to the SsrA-B regulon, and
the total number of SPI-2 effectors could be significantly
larger than previously anticipated.
A purified GST–SpvC fusion protein removed phos-
phate groups from phospho-Erk and phospho-JNK
in vitro, and its insensitivity to vanadate suggested that it
is not a typical tyrosine phosphatase. Subsequent mass
spectrometry analysis of both full-length Erk and a syn-
thetic phosphopeptide established that it acts as a phos-
phothreonine lysase, as has been shown for OspF of
S. flexneri (Li et al., 2007). A potential catalytic mecha-
nism has been proposed recently, based on an analysis of
the crystal structure of SpvC (Zhu et al., 2007). This form
of phosphate removal appears to be irreversible, which
might help to explain why we could detect the effects of
SpvC activity on levels of phospho-Erk in infected cells,
but not the bacterial effector itself.
The action of OspF on MAP kinases inhibits immune
responses by impairing the formation of histone H3-
phosphorylated and NF-kB-regulated promoters (Arbibe
et al., 2007). This is associated with a pronounced
decrease in IL-8 production by infected cells and reduced
recruitment of polymorphonuclear leucocytes to infected
tissues (Arbibe et al., 2007). It would appear that SpvC
performs a similar function in Salmonella. However, while
SpvC is clearly a phosphothreonine lyase, it is possible that
its substrate specificity and/or overall physiological effects
are different to OspF. The proteins share 63% amino acid
identity, and this could allow differential specificity towards
MAP kinases. In support of this, Arbibe et al. (2007)
reported that OspF is active towards Erk and p38, but not
JNK, while SpvC acts on Erk, p38 and JNK (Li et al., 2007;
and this work). A second possible means by which the
proteins could exert different activities results from the
spatio-temporal context in which they are produced: OspF
is injected by extracellular bacteria shortly after bacterial
contact with host cells and localizes to the nucleus, while
SpvC is translocated into the host cytoplasm relatively late
in the infective process from intracellular bacteria. Further-
more, whereas OspF accounted for strong suppression of
IL-8 transcription and secretion between 2 and 5 h follow-
ing bacterial invasion of Caco-2 cells, we did not observe
a significant difference between the wild-type or spvC
mutant strains in the levels of IL-8 produced from HeLa
cells, TNF-a released from mouse macrophages (despite
the clear difference in levels of phospho-Erk in infected
cells) or six cytokines that were tested in sera from infected
mice. Nevertheless, it seems likely that SpvC does inhibit
proinflammatory responses, because the complemented
mutant overexpressing SpvC caused a strong reduction
of IL-8 and TNF-a production in tissue cultured cells. It is
possible that the effects of SpvC produced by wild-type
bacteria are masked by other immune-modulating bacte-
rial molecules present in the infection assays. In vivo, SpvC
could help suppress localized proinflammatory responses
at infection foci in the spleen and liver, and thereby facilitate
bacterial growth. This would be consistent with our finding
that the spvC mutant does not have a replication defect in
tissue cultured macrophages, but is attenuated in the
mouse model of systemic infection.
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Experimental procedures
Bacterial strains and growth conditions
All bacterial strains used in this study are listed in Table S1.
Strains were grown in LB medium or a medium based on
magnesium minimal medium MES (MgM-MES), containing
170 mM 2-[N-morpholino]ethane-sulphonic acid at pH 5.0,
5 mM KCl, 7.5 mM (NH4)2SO4, 0.5 mM K2SO4, 1 mM KH2PO4,
8 mM MgCl2, 38 mM glycerol and 0.1% casamino acids
supplemented with appropriate antibiotics when necessary
(For E. coli: ampicilin 100 mg ml-1, kanamycin 50 mg ml-1,
chloramphenicol 50 mg ml-1; for Salmonella: ampicilin
50 mg ml-1, kanamycin 50 mg ml-1, chloramphenicol
50 mg ml-1 or tetracycline 12.5 mg ml-1), at 37°C with aeration
if not stated differently.
Construction of the spvC mutant strains and HA-tagging
of spvC on the virulence plasmid
Deletion of the spvC gene was performed by the method
of Datsenko and Wanner (2000), using primers Del-spvC-F
and Del-spvC-R (Table S2) to amplify the Cmr and Knr cas-
settes from pSU314 or pSU315 respectively. The resulting
PCR product was integrated into the chromosome of
S. Typhimurium expressing the l red recombinase from
pKD46. To excise the resistance marker the DspvC Kn strain
was transformed with pCP20 helper plasmid expressing
the FLP recombinase (Cherepanov and Wackernagel, 1995).
Deletion of the spvC gene was confirmed by PCR using
primers Del-F and Del-R which flank the deleted region.
Virulence plasmid-encoded spvC was double HA-tagged
using the procedure described by Uzzau et al. (2001). The
Cmr and Knr cassettes were amplified from pSU314 or
pSU315, respectively, using primers spvC-F and spvC-R and
the resulting PCR products were integrated into virulence
plasmid of various S. Typhimurium strains (Table S1).
Construction of plasmids
The bacterial plasmids used in this study are listed in
Table S1. To obtain pACYCspvC-2HA the double-HA-tagged
spvC was amplified from the virulence plasmid of spvC-2HA
strain using pacyc-F and pacycR2HA-C primers; the PCR
product was cloned into pACYC184 EcoRV and SalI sites. To
amplify spvC for cloning into BamHI and EcoRI sites of
pGEX4T2, primers pGEXspvC-F and pGEXspvC-R were
used. To amplify spvC for cloning into NdeI and XhoI sites of
pET22b, primers spvC-his-F and spvC-his-R were used.
Obtained plasmids were verified by sequencing.
Cell culture
HeLa (93021013) and J774 (91051511) cells were obtained
from the European Collection of Cell Cultures, Salisbury, UK.
Cells were grown in DMEM (Gibco, Carlsbad, CA) supple-
mented with 10% FCS at 37°C in 5% CO2.
Antibodies
Anti-Salmonella goat polyclonal antibody CSA-1 (Kirkegaard
and Perry Laboratories, Gaithersburg, MD) was used at a
dilution of 1:200. Anti-HA mouse monoclonal antibody (HA.
11; Covance) was used at a dilution of 1:200 (immunofluo-
rescence microscopy) and 1:1000 (Western blot). Anti-SseB
rabbit serum (Beuzon et al., 1999) was used at a dilution of
1:5000 for Western blot. Mouse monoclonal anti-pErk anti-
body (M8159, Sigma) was used at a dilution of 1:200 (immu-
nofluorescence) and 1:1000 (Western blot). Rabbit polyclonal
anti-Erk antibody (06–182, Upstate) was used at a dilution of
1:200 (immunofluorescence) and 1:1000 (Western blot). Cy2-
and Rhodamine red X (RRX)-conjugated donkey anti-goat,
anti-mouse or anti-rabbit antibodies (Jackson Immunore-
search Laboratories) were used for immunofluorescence at
a dilution of 1:200 and 1:400 for Cy5-conjugated antibody.
Anti-mouse and anti-rabbit HRP (Amersham Pharmacia
Biosciences) were used at a dilution of 1:10 000 for Western
blot analysis.
Mice infections
Female BALB/c mice (B and K Universal, UK) that were
7–12 weeks old were used in accordance with UK Home
Office regulations. To prepare the inocula, bacteria were first
grown overnight in LB broth and then subcultured at a dilution
of 1:100 for a further 2 h. Cultures were diluted to a concen-
tration of 2.5 ¥ 104 cfu ml-1 in physiological saline and mixed
for intraperitoneal inoculation (0.2 ml per mouse). Viable bac-
teria in inocula were quantified by dilution and plating onto
LB agar plates with appropriate antibiotics to distinguish
between strains. Mice were sacrificed at various times post
inoculation. The spleens were removed aseptically and
homogenized in distilled water by mechanical disruption in a
Colworth stomacher. Serial dilutions were plated on LB agar
for cfu enumeration. Strains were distinguished by differential
counting or replica plating on antibiotic-supplemented plates.
For each mouse, the CI or cancelled-out index (COI) was
calculated by dividing the output ratio (i.e. wild-type versus
mutant a, or mutant a versus mutant ab) divided by the input
ratio. The CI values were used to calculate means and in
statistical analyses. Student’s t-test was used to analyse the
COI of the single-mutant versus double-mutant strains (i.e.
mutant b versus mutant ab) with the null hypothesis that the
mean COI was equal to the CI of the wild-type versus the
single mutant (i.e. wild-type versus mutant a).
Infection of epithelial cells and macrophages
Infection of HeLa cells and macrophages was performed
as described (Beuzon et al., 2000; Ruiz-Albert et al., 2002).
Cells were fixed with paraformaldehyde, permeabilized and
incubated with antibodies as described (Beuzon et al., 2000).
Labelled cells were analysed by using a fluorescence micro-
scope (BX50; Olympus) or a confocal laser scanning micro-
scope (LSM510; Zeiss).
ELISA
HeLa cells or J774 macrophages were seeded at a density of
105 cells per well in 24-well Plate 24 h before challenge with
various Salmonella strains. At different time points after chal-
lenge plates were centrifuged at 400 g to settle down non-
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adherent cells. Supernatants were transferred into clean
tubes and stored at -80°C until the assay was performed.
Purified LPS (Sigma, St Louis, MO) at 1 mg ml-1 was used as
a positive control stimulus for TNF-a production by J774
macrophages. TNF-a and IL-8 levels were measured using
sandwich ELISA according to manufacturer’s recommenda-
tions (Diaclone, Stamford, CT).
Measurement of cytokines in mouse sera
Blood samples were collected at various time points after
bacterial challenge from intraperitoneally infected mice.
Animals were sacrificed and spleens were isolated for enu-
meration of bacteria. Blood was allowed to clot for 4 h at room
temperature and then overnight at 4°C. The clot was sepa-
rated by centrifugation and sera were stored at -80°C until
used for measurements. BDTM Cytometric Bead Array (BDTM
CBA, BD Biosciences, San Diego, CA) specific for IL-6, IL-10,
IL-12p70, MCP-1, IFN-g and TNF-a was used to test the sera.
Measurements were performed according to manufacturer’s
recommendations using BD FACSCaliburTM flow cytometer.
Protein secretion assay
To analyse protein production and secretion in SPI-2 T3SS
inducing conditions, Salmonella strains were grown overnight
in MgM-MES medium. Overnight cultures were subcultured
1:33 into a tube containing 5 ml of fresh growth medium, and
bacteria were allowed to grow for a further 6 h. To ensure
that protein from equal numbers of cells was analysed, in all
experiments protein samples were adjusted to OD600 values
such that a volume corresponding to 1 ml of a culture of OD600
0.5 was taken up in 100 ml of protein-denaturing buffer for gel
electrophoresis. The secreted and total bacterial fractions
were prepared as described before (Yu et al., 2002).
Protein purification
Plasmids for production of GST and GST fusion SpvC (GST–
SpvC) were transformed into E. coli TOP10 cells. Proteins
were induced by using IPTG (0.5 mM), and cells were lysed
using a French press. Samples were centrifuged at 38 000 g
for 45 min, and supernatants were incubated with Glu-
tathione Sepharose 4B beads (Amersham Pharmacia Bio-
sciences) at 4°C. The beads were washed extensively with
wash buffer (50 mM Tris-Cl, pH 8.0, 100 mM NaCl, 1 mM
DTT) and eluted in the same buffer containing 10 mM
glutathione. Samples were dialysed against 50 mM Tris-Cl,
pH 7.4, 50 mM NaCl. To dialysed samples, 20% glycerol was
added and aliquots were stored at -20°C. For purification of
six histidine-tagged SpvC, pET22bspvC-His was introduced
to E. coli BL21. Proteins were induced by using IPTG
(0.5 mM), and cells were lysed using a French press.
Samples were centrifuged at 38 000 g for 45 min, and super-
natant was incubated with Ni-NTA Agarose (Qiagen). The
beads were washed with wash buffer (20 mM Tris-Cl,
300 mM NaCl, 20 mM imidazole, 10% glycerol, pH 8.0) and
SpvC-His was eluted with elution buffer (20 mM Tris-Cl,
150 mM NaCl, 250 mM imidazole, 10% glycerol, pH 7.0).
Samples were dialysed in 50 mM Tris-Cl, pH 7.4, 50 mM
NaCl, 10% glycerol and stored at -20°C. Protein concentra-
tion was determined using Bio-Rad RC-DC assay with bovine
serum albumin as a standard. Protein purity was confirmed
through analysis of samples by SDS-PAGE (Fig. S1).
Dephosphorylation assay
For in vitro dephosphorylation reactions 100 ng of GST-pErk2
(pErk) (14–173, Upstate) was incubated with 30 U (1 mg) of
MAP-kinase phosphatase 1 (MKP1) 14–391, Upstate, 400 ng
of GST–SpvC, 400 ng of GST or left untreated as a positive
control for Erk phosphorylation in 100 mM TRIS-Cl pH 7.0,
50 mM NaCl (DB buffer) for 30 min at 30°C. The reactions
were stopped by boiling samples in SDS-PAGE sample
buffer. For orthovanadate inhibition, an appropriate amount of
activated Na3VO4 was added to the DB buffer. The phospho-
rylation state of Erk was assessed by Western blot analysis.
For mass spectrometry pErk or pErk-derived phosphopeptide
(1 mg) were incubated with 400 ng of SpvC-His for 1 h at
30°C in DB buffer. The mixture of pErk and SpvC was sepa-
rated on a precast Bio-Rad Tris-Glycine acrylamide gel and
the band corresponding to pErk was then excised and used
for in-gel tryptic digestion. The pErk-derived peptide was
used directly for mass spectrometry analysis.
In-gel tryptic digestion
In-gel tryptic digestion of SDS-PAGE bands was performed
after reduction with DTT and S-carbamidomethylation with
iodoacetamide. Gel pieces were washed three times with
50% (v/v) aqueous acetonitrile containing 25 mM ammonium
bicarbonate and dried in a vacuum concentrator for 30 min.
Sequencing-grade, modified porcine trypsin (Promega) was
dissolved in the 50 mM acetic acid supplied by the manu-
facturer, and then diluted fivefold by adding 25 mM ammon-
ium bicarbonate to give a final trypsin concentration of
0.02 mg ml-1. Gel pieces were rehydrated by adding 10 ml of
trypsin solution, and after 30 min enough trypsin solution was
added to cover the gel pieces. Digests were incubated over-
night at 37°C.
MALDI-TOF mass spectrometry
A 0.5 ml aliquot of peptide or tryptic digest was applied directly
to a MALDI target plate, followed immediately by an equal
volume of a freshly prepared 5 mg ml-1 solution of a-cyano-
4-hydroxycinnamic acid (Sigma, Poole, UK) in 50% aqueous
(v/v) acetonitrile containing 0.1% TFA (v/v). Positive ion mass
spectra were obtained using an Applied Biosystems 4700
Proteomics Analyzer (Applied Biosystems, Foster City, CA,
USA) in reflectron mode. MS spectra were acquired with a
total of 1000 laser pulses over a mass range of m/z 800–4000
with a focus mass of m/z 1500. CID-MS/MS spectra were
acquired using a collision energy of 1 kV with air as the gas
at a Source 2 pressure of about 1 ¥ 10-6 torr. The precursor
mass window was set to a relative resolution of 50, and the
metastable suppressor was enabled. MS/MS spectra were
baseline-subtracted (peak width 50) and smoothed (Savitsky-
Golay with three points across a peak and polynomial order
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4) Peak detection used a minimum S/N of 5, local noise
window of 50 m/z, and minimum peak width of 2.9 bins.
LC-electrospray (ES) mass spectrometry
Peptide separations were achieved using a 5 cm
polystyrene-divinlybenzene (PS-DVB) monolithic column
(100 mm inside diameter) and UltiMate capillary HPLC
system (Dionex, Sunnyvale, CA, USA) with the column at
60°C. Samples (3 ml) were injected directly onto the column
and eluted with a linear gradient of acetonitrile in 0.1% formic
acid from 2 to 50% in 10 min at a flow rate of 1.1 ml min-1.
Peptides eluting from the column were analysed using a
QSTAR Pulsar i hybrid mass spectrometer (Applied Biosys-
tems, Foster City, CA, USA) with Analyst QS software and
fitted with a modified MicroIonSpray source. The mass spec-
trometer was operated in information-dependent acquisition
mode with an MS survey scan of 1 s and two 0.5 s MS/MS
spectra acquired per experiment. Precursor masses were
excluded for 120 s after selection, and the collision offset was
selected automatically.
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